Conmed (CNMD) Total Current Liabilities (2010 - 2026)
Conmed's (CNMD) quarterly Total Current Liabilities came in at $455.4 million in Q2 2026, up 54.46% YoY from $294.8 million in Q2 2025, and up 55.58% on a QoQ basis from $292.7 million in Q1 2026.
Conmed (CNMD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Total Current Liabilities data on file, last reported at $455.4 million in Q2 2026.
- Quarterly Total Current Liabilities rose 54.46% year-over-year to $455.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $455.4 million (up 54.46% YoY) and the FY2025 annual result came in at $315.0 million, up 13.27% from the prior year.
- Total Current Liabilities climbed to $455.4 million in Q2 2026, from $292.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $455.4 million in Q2 2026 to a low of $187.6 million in Q1 2022.
- A 5-year average of $296.0 million and a median of $293.8 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities soared 80.42% — and 2024, when it retreated 24.98%.
- Tracing CNMD's Total Current Liabilities over 5 years: stood at $296.6 million in 2022, then gained by 4.78% to $310.7 million in 2023, then declined by 10.49% to $278.1 million in 2024, then advanced by 13.27% to $315.0 million in 2025, then surged by 44.55% to $455.4 million in 2026.
- The last three Total Current Liabilities figures came in at $455.4 million (Q2 2026), $292.7 million (Q1 2026), and $315.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | 455.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 455.40 Mn |
| Mar 31, 2026 | 292.72 Mn |
| Dec 31, 2025 | 315.04 Mn |
| Sep 30, 2025 | 314.70 Mn |
| Jun 30, 2025 | 294.84 Mn |
| Mar 31, 2025 | 283.15 Mn |
| Dec 31, 2024 | 278.13 Mn |
| Sep 30, 2024 | 282.31 Mn |
| Jun 30, 2024 | 266.41 Mn |
| Mar 31, 2024 | 291.40 Mn |
| Dec 31, 2023 | 310.73 Mn |
| Sep 30, 2023 | 376.32 Mn |
| Jun 30, 2023 | 353.17 Mn |
| Mar 31, 2023 | 320.69 Mn |
| Dec 31, 2022 | 296.55 Mn |
| Sep 30, 2022 | 208.58 Mn |
| Jun 30, 2022 | 201.09 Mn |
| Mar 31, 2022 | 187.60 Mn |
| Dec 31, 2021 | 196.65 Mn |
| Sep 30, 2021 | 183.19 Mn |